CBLL (CBLL) Stock

Healthcare · Medical Devices · Member of Other US Stocks

CBLL (CBLL) closed at USD 26.37 on 2026-10-14, a change of +105.5 % over the past year, with a market capitalization of USD 1.06B.

CBLL recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

CBLL key figures

Previous close

USD 26.37 (2026-10-14)

1-year change

+105.5 %

Market cap

USD 1.06B

Enterprise value

USD 953.42M

P/E ratio (trailing)

-14.86

P/E ratio (forward)

-17.13

EPS (trailing)

-1.86

EPS (forward)

-1.61

PEG ratio

n/a

Price to book

8.23

Revenue growth

32.5 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.70

Employees

327

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About CBLL

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for CBLL and compare it with other stocks.